Skip to main content

Log In To:

Support

What We Do
Products
- SciFinderⁿ
- SciFinder
- STN
- MethodsNow
- NCI Global
- PatentPak
- ChemZent
- CHEMCATS
- Science IP
Services
Resources
Blog
About
- CAS Story
- CAS Content
- Events
- FAQs
- Future Leaders
- Careers
Contact

What We Do
Products
- SciFinderⁿ
- SciFinder
- STN
- MethodsNow
- NCI Global
- PatentPak
- ChemZent
- CHEMCATS
- Science IP
Services
Resources
Blog
About
- CAS Story
- CAS Content
- Events
- FAQs
- Future Leaders
- Careers
Contact

Log In To:

Support

Accelerate Innovation

Accelerate Innovation

What if you could double the size of your research team overnight? CAS will help you harness scientific information to spark creativity and drive efficiencies.

Manage Information

Manage Information

The volume of information today is overwhelming. CAS will help make sure your organization always has access to exactly the right information at the right time.

Increase ROI

Market competition is fierce and your resources are limited. CAS solutions will help you maximize the value of every investment.

Protect Intellectual Property

Protect Intellectual Policy

When managing intellectual property, the last thing you want is surprises. CAS will provide a complete view of the landscape so you can make important decisions with confidence.

Research shows that users of today’s information tools spend far too much time trying to find relevant, actionable results. SciFinderⁿ, the newest product in the SciFinder® family, accelerates that process with a frictionless interface to the unmatched CAS content collection and the most advanced chemistry relevance engine in the industry.

SciFinder® is your portal to chemistry and related information providing easy access to the most trusted collection of chemical substances, reactions and literature references in the world curated by expert scientists, not robots.

STN® is the premier single source for searching the world's disclosed scientific and technical research.

The foundation of most scientific research is the detailed description of the experimental and analytical techniques utilized in the lab. Finding these methods and protocols in the literature is an arduous and time consuming effort.

Constantly changing regulations and expanding global markets make it challenging to stay on top of compliance requirements. NCI Global is a single resource for up-to-date regulatory information on hundreds of thousands of chemical compounds regulated worldwide. With coverage of nearly 150 international regulatory inventories and lists, NCI Global makes it easy to search by CAS Registry Numbers®, chemical names, and more.

PatentPak® is an integrated workflow solution designed to radically reduce time spent acquiring and searching through full-text patents to find vital chemistry insights.

As scientists work on solving the problems of today, there is much to be learned from the past. Information gaps in your collection can cause wasted time and missed opportunities. ChemZent makes historical research accessible by providing an essential resource, Chemisches Zentralblatt to anyone researching chemistry.

CHEMCATS is the market-leading index of commercially available chemicals and their worldwide suppliers. Integrated in SciFinder®, CHEMCATS provides verified available quantities, prices and supplier contact information for millions of commercially available chemical products from hundreds of suppliers.

Science IP® searches the world’s scientific and technical literature to discover answers and insight that drive confident business decisions.

Technology Services

Platform infrastructure, search technology, and data architecture are the cornerstones of our successful information solutions. Put the CAS technology team that built them to work on your biggest data integration challenges.

Content Services

Our highly structured big data environment comprehensively covers chemical sciences and related research information. License direct access to the complete CAS content collection, or commission our scientists to create a customized collection built to your unique specifications.

Knowledge Services

When the stakes are high and you need reliable advice and insight, call on the experts at CAS to help you assess risk, find opportunity, and stay ahead of the competition.

Professional Services from CAS

Keep your projects on track with help from CAS. Augment your internal capabilities and competencies by leveraging our team of experienced scientists, analysts, writers, technologists, informaticians, and business people.

Film Patents

By any measure, global innovation is accelerating at a dizzying pace. R&D spending, global patent applications, venture capital investment volume, and the pace of technology M&A all reflect the increase in activity.

Markush

Peter Blasi of CAS investigates the pros and cons of scientific intellectual property, specifically thinking about Markush structures and their complications under patent law.

Licensing Cycle

Anne Marie Clark of CAS examines some common pitfalls and considerations required for successful tech transfer to the business community.

See all Articles

Aptean and CAS now offer CAS Biosequences content in GenomeQuest. Combining the CAS Biosequences Module and the GQ-Pat database on a single platform delivers a unique, comprehensive “one-stop” search solution for biotechnology intellectual property.

AMRI, a leading global CRO, signs a 5-year Agreement for SciFinder from CAS.

INPI and CAS collaborate to improve patent application examination efficiency with new AI approach. CAS indexing data combined with advanced graph database technologies is proving to be an effective solution to improve patent processing.

See all Press Releases

Thumbnail image for Vaccine R&D whitepaper

Vaccines are a cost-effective and durable medical strategy for disease prevention in public health efforts worldwide. As the focus of medicine expands from disease treatment to disease prevention, the vaccine industry should witness even more rapid development. This CAS whitepaper looks at key R&D trends.

Gene Cell Therapy

This CAS whitepaper identifies major trends in gene and cell therapy R&D that may help to predict future developments and pinpoint opportunities for therapeutic applications in the treatment of various diseases.

Fusion Proteins

With rapid advances in recombinant DNA and protein engineering technologies, therapeutic fusion proteins have emerged as a new option for biologics with improved pharmacokinetic stability and enhanced capability to act on molecular targets. Fusion proteins have also facilitated the development of new vaccines, and gene and cell therapy drugs to address other clinical challenges.

See all Whitepapers

See how CAS is partnering with Cisco to meet today’s scientific big data challenges and plan for a sustainable future.

See how leading Japanese generic pharmaceutical company Nippon Chemiphar realized considerable gains in efficiency and productivity by switching to STN Global Value Pricing allowing them to achieve their aggressive annual development goals.

See all Case Studies

See all results

No results for your query.

Check the spelling in your query or search for a new term.

Site search accepts advanced operators to help refine your query. Learn more.

Licensing Cycle

Licensing Cycle

Home
Resources
Articles
Taking IP to the bank: Tech transfer pitfalls to avoid

Taking IP to the bank: Tech transfer pitfalls to avoid

Anne Marie Clark of CAS examines some common pitfalls and considerations required for successful tech transfer to the business community.

Download

Legal
Privacy
Site Map
Accessibility
京ICP备13047075号-3

ACS
Publications
C&EN

LinkedIn
Twitter
Facebook
YouTube

CAS, P.O. Box 3012, Columbus, Ohio 43210 U.S.A.

help@cas.org, 800-848-6538 (North America), 614-447-3600 (worldwide)

Copyright © 2019 American Chemical Society